5035 – DotDiver ANA PCNA

Intended Purpose

The DotDiver ANA PCNA is a qualitative dot immunoassay for the determination of IgG antibodies against nuclear and cytoplasmic antigens (Sm, RNP, Sm/RNP, SSA(Ro), SSB(La), Jo-1, Scl-70, PM-Scl, Ku, CENPA/B, PCNA and Ribosome P0) in human serum. The DotDiver ANA PCNA is intended as an aid in the diagnosis of systemic autoimmune diseases in conjunction with other clinical and laboratory findings. The immunoassay is designed for semi-automated use with the DotDiver instrument. The immunoassay is designed for professional in vitro diagnostic use.


Diagnostic Relevance

The appearance of autoantibodies directed against components of the cell nucleus are characteristic features of systemic autoimmune diseases, especially; systemic lupus erythematosus (SLE), Sjögren’s syndrome, progressive systemic sclerosis (PSS), mixed connective tissue disease (MCTD), rheumatoid arthritis (RA) and dermatomyositis. The detection of auto-antibodies in patient sample, e.g. plasma and serum, is well established and plays an essential role in the diagnosis of systemic autoimmune diseases.

Product Specifications

Title DotDiver ANA PCNA
Product code 5035
Indication Systemic autoimmune diseases
Description Dot immunoassay for the qualitative determination of IgG antibodies against nuclear and cytoplasmic antigens in human serum
Format Test strips coated with Sm, RNP, Sm/RNP, SSA(Ro), SSB(La), Jo-1, Scl-70, PM-Scl, Ku, CENPA/B, PCNA and Ribosome P0
Total incubation time 64 min.
Sample volume 10 µL serum
No. of determinations 24 x 12

Free downloads

  SDS [REF 5035][ENG]   SDS [REF 5035][DEU]

Restricted downloads - Password required